These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9174407)

  • 21. The search for a vaccine against schistosomiasis--a difficult path but an achievable goal.
    McManus DP
    Immunol Rev; 1999 Oct; 171():149-61. PubMed ID: 10582169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can schistosomiasis really be consigned to history without a vaccine?
    Bethony JM; Diemert DJ; Oliveira SC; Loukas A
    Vaccine; 2008 Jun; 26(27-28):3373-6. PubMed ID: 18513839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application of reverse vaccinology in Schistosoma vaccine development: advances and prospects].
    Feng XG; Sui CY; Yuan CX; Shao DH; Chen JX; Lin JJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):237-47. PubMed ID: 18038788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advancing a vaccine to prevent human schistosomiasis.
    Merrifield M; Hotez PJ; Beaumier CM; Gillespie P; Strych U; Hayward T; Bottazzi ME
    Vaccine; 2016 Jun; 34(26):2988-2991. PubMed ID: 27036511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refolding of the recombinant protein Sm29, a step toward the production of the vaccine candidate against schistosomiasis.
    Chura-Chambi RM; Nakajima E; de Carvalho RR; Miyasato PA; Oliveira SC; Morganti L; Martins EA
    J Biotechnol; 2013 Dec; 168(4):511-9. PubMed ID: 24084635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Future vaccines in parasitology].
    Lagardère B
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):926-34. PubMed ID: 1819438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schistosomes--proteomics studies for potential novel vaccines and drug targets.
    DeMarco R; Verjovski-Almeida S
    Drug Discov Today; 2009 May; 14(9-10):472-8. PubMed ID: 19429506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A vaccine against Asian schistosomiasis.
    McManus DP; Bartley PB
    Parasitol Int; 2004 Jun; 53(2):163-73. PubMed ID: 15081948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relevance of a partial immunity-inducing anti-schistosomiasis vaccine in endemic areas.
    el Ridi R
    J Parasitol; 1995 Feb; 81(1):104. PubMed ID: 7876961
    [No Abstract]   [Full Text] [Related]  

  • 30. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials.
    Capron A; Riveau G; Capron M; Trottein F
    Trends Parasitol; 2005 Mar; 21(3):143-9. PubMed ID: 15734662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydatid disease: vaccinology and development of the EG95 recombinant vaccine.
    Gauci C; Heath D; Chow C; Lightowlers MW
    Expert Rev Vaccines; 2005 Feb; 4(1):103-12. PubMed ID: 15757477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leishmania vaccines: progress and problems.
    Kedzierski L; Zhu Y; Handman E
    Parasitology; 2006; 133 Suppl():S87-112. PubMed ID: 17274851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress towards a vaccine for schistosomiasis.
    Pearce EJ
    Acta Trop; 2003 May; 86(2-3):309-13. PubMed ID: 12745147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine development against schistosomiasis from concepts to clinical trials.
    Capron A; Capron M; Riveau G
    Br Med Bull; 2002; 62():139-48. PubMed ID: 12176856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on paramyosin in parasitic worms.
    Gobert GN; McManus DP
    Parasitol Int; 2005 Jun; 54(2):101-7. PubMed ID: 15866471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?
    Bergquist NR; Leonardo LR; Mitchell GF
    Trends Parasitol; 2005 Mar; 21(3):112-7. PubMed ID: 15734657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of human schistosomiasis control: Challenges and prospects.
    Fenwick A; Rollinson D; Southgate V
    Adv Parasitol; 2006; 61():567-622. PubMed ID: 16735173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in proteomic applications for schistosomiasis research: potential clinical impact.
    Sotillo J; Doolan D; Loukas A
    Expert Rev Proteomics; 2017 Feb; 14(2):171-183. PubMed ID: 27937063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schistosomiasis in Egypt: A never-ending story?
    Othman AA; Soliman RH
    Acta Trop; 2015 Aug; 148():179-90. PubMed ID: 25959770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.